News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–77
Matches
77
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

77 matching headlines

Ticker or company: WSTMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Market source Earnings Main company 🇺🇸 United States

West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

West Pharmaceutical Services (WST) is projected to report increased earnings and higher revenues for the quarter ended June 2026, with an expected EPS of $2.08, up 13% year-over-year, and revenues of $836.8 million, up 9.2%. The company's Zacks Earnings ESP of +0.66% combined with …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Moomoo Analyst action Main company 🇺🇸 United States

TD Cowen Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $410

TD Cowen has reiterated its Buy rating for West Pharmaceutical Services (WST.US) and increased its price target to $410. This indicates a continued positive outlook from the analyst firm on the company's stock performance.

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical Services (WST) is a strong candidate for investment due to robust demand for its High-Value Products, the expansion of GLP-1 drug programs, and regulatory changes like Annex 1 conversions. While the company faces challenges such as concentration risk from GLP-1 therapies and …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sharemaestro News Company research Main company 🇺🇸 United States

West Pharmaceutical’s 42.7% quarter reaches range top with only 0.8x volume

West Pharmaceutical Services closed just 0.5% below its 52-week high after a strong three-month advance, but the latest week’s participation was below average.

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sharemaestro News Company research Main company 🇺🇸 United States

West Pharma nears its 52-week high as medical-supplies peers fall behind

West Pharmaceutical Services added 4.6% for the week and sits just 2.4% below its 52-week high, but participation remains ordinary and Market Dynamics has cooled from earlier June readings.

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context